Aptose Biosciences Patents – Insights & Stats

Aptose Biosciences has a total of 161 patents globally, out of which 69 have been granted. Of these 161 patents, more than 37% patents are active. The United States of America is where Aptose Biosciences has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, The United States of America seems to be the main focused R&D center and also USA is the origin country of Aptose Biosciences.

Aptose Biosciences was founded in the year 1986. The Company operates as pharmaceutical company and focuses on the development of cancer therapies and treatment of pancreatic cancer.

Do read about some of the most popular patents of Aptose Biosciences which have been covered by us in this article and also you can find Aptose Biosciences patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Aptose Biosciences patent portfolio.

How many patents does Aptose Biosciences have?

Aptose Biosciences has a total of 161 patents globally. These patents belong to 36 unique patent families. Out of 161 patents, 60 patents are active.

How Many Patents did Aptose Biosciences File Every Year?

Aptose Biosciences Patents Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantAptose Biosciences Applications FiledAptose Biosciences Patents Granted
20232
202262
20211010
202072
2019124
2018212
201783
201632
201523
2014212
201311
20122
20112

How many Aptose Biosciences patents are Alive/Dead?

Worldwide Patents

Aptose Biosciences Patents Portfolio

How Many Patents did Aptose Biosciences File in Different Countries?

Aptose Biosciences Worldwide Patents

Countries in which Aptose Biosciences Filed Patents

CountryPatents
United States Of America37
Europe18
Japan14
Austria9
Germany8
Australia7
Spain7
Hong Kong (S.A.R.)7
China6
Korea (South)6
New Zealand5
Canada4
Mexico3
Israel3
Taiwan2
Denmark2
Singapore1
India1
Russia1
Argentina1
Norway1
Macao1

Where are Research Centers of Aptose Biosciences Patents Located?

Research Centers of Aptose Biosciences Patents

10 Best Aptose Biosciences Patents

WO2006017932A1 is the most popular patent in the Aptose Biosciences portfolio. It has received 23 citations so far from companies like Novartis Ag, and Arrowhead Pharmaceuticals.

Below is the list of 10 most cited patents of Aptose Biosciences:

Publication NumberCitation Count
WO2006017932A123
US8148392B221
WO2018098561A118
WO2004104197A117
WO2005065719A115
US6593305B111
US7884120B211
US8394815B28
US8969372B28
US10921240B16

What Percentage of Aptose Biosciences US Patent Applications were Granted?

Aptose Biosciences (Excluding its subsidiaries) has filed 20 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 14 have been granted leading to a grant rate of 82.3%.

Below are the key stats of Aptose Biosciences patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Aptose Biosciences?

Law FirmTotal ApplicationsSuccess Rate
Cooley Llp2082.35%

What are Aptose Biosciences key innovation segments?

What Technologies are Covered by Aptose Biosciences?

The chart below distributes patents filed by Aptose Biosciences in different countries on the basis of the technology protected in patents. It also represents the markets where Aptose Biosciences thinks it’s important to protect particular technology inventions.

R&D Focus: How has Aptose Biosciences search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Aptose Biosciences?

Related Articles

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.